03
Mar

Fresh from floating plans to raise up to $364 million in an IPO for his life sciences fund, ex-Elan chief Kelly Martin is going into the biopharma business with his former chief medical officer, Menghis Bairu. Martin announced today that he’s sinking up to $43 million into Bairu’s newborn Serenus Biotherapeutics with plans to gain a majority interest in the company.

…read more

Source: Bullish ex-Elan chief plots a $43M buy-in for upstart Serenus

    

0 No comments